# Recombinant Human Brain Natriuretic Peptide for the Recovery Stage of Septic Shock

> **NCT06745206** · NA · NOT_YET_RECRUITING · sponsor: **Sichuan Provincial People's Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Sepsis-induced Cardiomyopathy
- the Recovery Phase of Septic Shock

## Interventions

- **DRUG:** Lyophilized Recombinant Human Brain Natriuretic Peptide

## Key facts

- **NCT ID:** NCT06745206
- **Lead sponsor:** Sichuan Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2026-06
- **Final completion:** 2026-09
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06745206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06745206, "Recombinant Human Brain Natriuretic Peptide for the Recovery Stage of Septic Shock". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06745206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*